Folic acid supplementation increases survival and modulates high risk HPV-induced phenotypes in oral squamous cell carcinoma cells and correlates with p53 mRNA transcriptional down-regulation

Cancer Cell International

Volumn 12, Issue , 2012, Pages

  Moody, Michael ^a   Le, Oanh ^a   Rickert, Megan ^a   Manuele, Jeremy ^a   Chang, Sarah ^a   Robinson, Gary ^a   Hajibandeh, Jeffrey ^a,b   Silvaroli, John ^a,c   Keiserman, Mark A ^d   Bergman, Christine J ^a   Kingsley, Karl ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b Howard Hughes Medical Institute   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Folate; Human papillomavirus; Oral cancer

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; MESSENGER RNA; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CANCER RISK; CANCER SURVIVAL; CELL VIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IN VITRO STUDY; MOUTH CANCER; PAPILLOMAVIRUS INFECTION; STRAIN DIFFERENCE; TRANSCRIPTION REGULATION; TUMOR GROWTH; VITAMIN SUPPLEMENTATION; WART VIRUS;

EID: 84862811083     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-12-10     Document Type: Article

References (65)

1. Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 2000, 53:165-172. 10.1136/mp.53.4.165, 1186964, 11040937.
2. Campo-Trapero J, Cano-Sanchez J, Palacios-Sanchez B, Sanchez-Gutierrez JJ, Gonzalez-Moles MA, Bascones-Martinez A. Update on molecular pathology in oral cancer and precancer. Anticancer Res 2008, 28:1197-1205.
3. Marshberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993, 72:1369-1375. 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L, 8339227.
4. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1998, 489:3282-3287.
5. La Vecchia C, Negri E, Pelucchi C, Franceschi S. Dietary folate and colorectal cancer. Int J Cancer 2002, 102:545-547. 10.1002/ijc.10720, 12432561.
6. Poschl G, Stickel F, Wang SX, Seitz HK. Alcohol and cancer: genetic and nutritional aspects. Proc Nutr Soc 2004, 63:65-71. 10.1079/PNS2003323, 15070439.
7. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92(9):709-720. 10.1093/jnci/92.9.709, 10793107.
8. van Houten VM, Snijders PF, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001, 93:232-235. 10.1002/ijc.1313, 11410871.
9. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, Califano JA. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002, 8(5):1203-1209.
10. Dai M, Clifford GM, le Calvez F, Castellsague X, Snijders PJ, Pawlita M, Herrero R, Hainaut P, Franceschi S. Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res 2004, 64(2):468-471. 10.1158/0008-5472.CAN-03-3284, 14744758.
11. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248(4951):76-79. 10.1126/science.2157286, 2157286.
12. Kingsley K, Johnson D, O'Malley S. Transfection of oral squamous cell carcinoma with human papillomavirus-16 induces proliferative and morphological changes independent of cellular adhesion in vitro. Cancer Cell Int 2006, 6:14. 10.1186/1475-2867-6-14, 1550262, 16716227.
13. Reddout N, Christensen T, Bunnell A, Jensen D, Johnson D, O'Malley S, Kingsley K. High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect Agent Cancer 2007, 2(1):21. 10.1186/1750-9378-2-21, 2206007, 18001474.
14. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
15. Burnett TS, Sleeman JP. Uneven distribution of methylation sites within the human papillomavirus la genome: possible relevance to viral gene expression. Nucleic Acids Res 1984, 12:8847-8860. 10.1093/nar/12.23.8847, 320423, 6096809.
16. List HJ, Patzel V, Zeidler U, Schopen A, Ruhl G, Stollwerk J, Klock G. Methylation sensitivity of the enhancer from the human papillomavirus type 16. J Biol Chem 1994, 269:11902-11911.
17. Stunkel W, Huang Z, Tan SH, O'Connor M, Bernard HU. Nuclear matrix attachment regions of human papillomavirus-16 repress or activate the E6 promoter depending on the physical state of the viral DNA. J Virol 2000, 74:2489-2501. 10.1128/JVI.74.6.2489-2501.2000, 111737, 10684263.
18. Paulsen M, Ferguson-Smith AC. DNA methylation in genomic imprinting, development, and disease. J Pathol 2001, 195:97-110. 10.1002/path.890, 11568896.
19. Badal V, Chuang LSH, Tan EHH, Badal S, Villa LL, Wheeler CM, Li BFL, Bernard HU. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 2003, 77:6277-6234.
20. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr 1989, 50:508-516.
21. Bailey LB, Gregory JF. Folate metabolism and requirements. J Nutr 1999, 129:779-782.
22. Eto I, Krumkeick CL. Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv Exp Med Biol 1986, 206:313-330.
23. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Golditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Nat Cancer Inst 1995, 87:265-273. 10.1093/jnci/87.4.265, 7707417.
24. Rothenberg SP. Increasing the dietary intake of folate: pros and cons. Semin Hematol 1999, 36:65-74.
25. Flynn MA, Anderson WA, Burke SJ, Reilly A. Session 1: Public health nutrition. Folic acid food fortification: the Irish experience. Proc Nutr Soc 2008, 67:381-389. 10.1017/S0029665108008720, 18847514.
26. La Vecchia C, Franceschi S, Levi F, et al. Diet and human oral carcinoma in Europe. Eur J Cancer B Oral Oncol 1993, 29B:17-22.
27. Pelucchi C, Talamini R, Negri E, Levi F, Conti E, Franceschi S, La Vecchia C. Folate intake and risk of oral and pharyngeal cancer. Ann Oncol 2003, 13:1677-1681.
28. Gabriel HE, Crott JW, Ghandour H, Dallal GE, Choi SW, Keyes MK, Jang H, Liu Z, Nadeau M, Johnston A, Mager D, Mason JB. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 2006, 83:835-841.
29. Capaccio P, Ottaviani F, Cuccarini V, Cenzuales S, Cesana BM, Pignataro L. Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy. J Laryngol Otol 2005, 119:371-376.
30. Vairaktaris E, Yapijakis C, Kessler P, Vylliotis A, Ries J, Wiltfang J, Vassiliou S, Derka S, Neukam FW. Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 2006, 132:219-222. 10.1007/s00432-005-0065-5, 16365753.
31. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999, 340:1449-1454. 10.1056/NEJM199905133401901, 10320382.
32. Dietrich M, Brown CJ, Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 2005, 24:266-274.
33. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Screening Trial. Am J Clin Nutr 2006, 83:895-904.
34. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007, 297:2351-2359. 10.1001/jama.297.21.2351, 17551129.
35. Kingsley K, Zuckerman J, Davis M, Matteucci M, Knavel A, Rinehart J, Tran V, Woyciehowsky D, Jenkins P, Yu R, Nguyen DH, O'Malley S. Induction of Differential Growth in vitro by High-risk Human Papillomavirus in Human Breast Cancer Cell Lines is Associated with Caspase Dysregulation. J Cancer and Ther 2009, 1(2):62-71.
36. McCabe J, Hajibandeh J, Tran MD, Meeder CA, Sharma K, Nguyen DH, Moody M, Keiserman MA, Bergman CJ, Kingsley K. Folate supplementation induces differential dose-dependent modulation of proliferative phenotypes among cancerous and non-cancerous oral cell lines in vitro. J Diet Suppl 2010, 7(4):325-340. 10.3109/19390211.2010.522552, 22432562.
37. Bailey RL, Dodd KW, Gahche JJ, Dwyer JT, McDowell MA, Yetley EA, Sempos CA, Burt VL, Radimer KL, Picciano MF. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am J Clin Nutr 2010, 91(1):231-237. 10.3945/ajcn.2009.28427, 2793110, 19923379.
38. Matsue H, Rothberg KG, Takashima A, Kamen BA, Anderson RG, Lacey SW. Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc Natl Acad Sci USA 1992, 89:6006-6009. 10.1073/pnas.89.13.6006, 402127, 1631087.
39. King M, Chatelain K, Farris D, Jensen D, Pickup J, Swapp A, O'Malley S, Kingsley K. Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complement Altern Med 2007, 7:22. 10.1186/1472-6882-7-22, 1914364, 17578576.
40. Hays WL. Inferences about population means. Statistics 1994, 311-42. International Thomson Publishing, 5.
41. Mu LN, Cao W, Zhang ZF, Yu SZ, Jiang QW, You NC, Lu QY, Zhou XF, Ding BG, Chang J, Chen CW, Wei GR, Cai L. Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers 2007, 12(1):61-75. 10.1080/13547500600945101, 17438654.
42. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113. 10.1038/ng0595-111, 7647779.
43. van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 1998, 62:1044-1051. 10.1086/301825, 1377082, 9545395.
44. Wolter F, Turchanowa L, Stein J. Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis 2003, 24:469-474. 10.1093/carcin/24.3.469, 12663506.
45. Vakifahmetoglu H, Olsson M, Orrenius S, Zhivotovsky B. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 2006, 25:5683-5692. 10.1038/sj.onc.1209569, 16652156.
46. Chatelain K, Phippen S, McCabe J, Teeters CA, O'Malley S, Kingsley K. Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas. Evid Based Complement Alternat Med 2008,
47. Kingsley K, Jensen D, Toponce R, Dye J, Martin D, Phippen S, Ross D, Halthore VS, O''Malley S. Inhibition of Oral Cancer Growth in Vitro Is Modulated Through Differential Signaling Pathways by Over-the-Counter Proanthocyanidin Supplements. J Diet Suppl 2010, 7(2):130-144. 10.3109/19390211003781685, 22435612.
48. Weinstein SJ, Gridley G, Harty LC, Diehl SR, Brown LM, Winn DM, Bravo-Otero E, Hayes RB. Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr 2002, 132:762-767.
49. Vairaktaris E, Yapijakis C, Kessler P, Vylliotis A, Ries J, Wiltfang J, Vassiliou S, Derka S, Neukam FW. Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 2006, 132:219-222. 10.1007/s00432-005-0065-5, 16365753.
50. Hsu S, Singh B, Schuster G. Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention. Oral Oncol 2004, 40(5):461-73. Review, 10.1016/j.oraloncology.2003.09.012, 15006617.
51. Lun M, Zhang PL, Pellitteri PK, Law A, Kennedy TL, Brown RE. Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB. Ann Clin Lab Sci 2005, 35:251-258.
52. Skvortsov S, Skyortsova I, Stasyk T, Schiefermeier N, Neher A, Gunkel AR, Bonn GK, Huber LA, Lukas P, Pleiman CM, Zwierzina H. Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-kappaB expression and proteasome activation in head and neck squamous carcinoma cell lines. Mol Cancer Ther 2007, 6:1898-1908. 10.1158/1535-7163.MCT-06-0708, 17575118.
53. Bock JM, Menon SG, Goswami PC, Sinclair LL, Bedford NS, Jackson RE, Trask DK. Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition. Cancer Biol Ther 2007, 6:30-39. 10.4161/cbt.6.1.3470, 17172818.
54. Kingsley K. Potential effects of dietary folate supplementation on oral carcinogenesis, development and progression. J Diet Suppl 2010, 7(1):51-59. 10.3109/19390210903535019, 22435573.
55. Rosl FA, Arab A, Klevenz B, zur Hausen H. The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol 1993, 74:791-801. 10.1099/0022-1317-74-5-791, 8388016.
56. Thain A, Jenkins O, Clarke AR, Gaston K. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 1996, 70:7233-7235. 190779, 8794373.
57. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002, 21(48):7435-7451. 10.1038/sj.onc.1205803, 12379884.
58. Cox LA, Sanders E. Estimating preventable fractions of disease caused by a specified biological mechanism: PAHs in smoking lung cancers as an example. Risk Anal 2006, 26(4):881-892. 10.1111/j.1539-6924.2006.00785.x, 16948683.
59. Francis DA, Schmid SI, Howley PM. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J Virol 2000, 74:2679-2686. 10.1128/JVI.74.6.2679-2686.2000, 111757, 10684283.
60. Dahler AL, Jones SJ, Dicker AJ, Saunders NA. Keratinocyte growth arrest is associated with activation of a transcriptional repressor element in the human cdk1 promoter. J Cell Physiol 1998, 177(3):474-482. 10.1002/(SICI)1097-4652(199812)177:3<474::AID-JCP10>3.0.CO;2-M, 9808155.
61. Qiu W, Schonleben F, Li X, Su GH. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer Lett 2007, 245(1-2):163-170. 10.1016/j.canlet.2006.01.003, 1741856, 16478646.
62. Tsai WC, Lin YC, Tsai ST, Shen WH, Chao TL, Lee SL, Wu LW. Lack of modulatory function of coding nucleotodie polymorphism S100A2 185 G > A in oral squamous cell carcinoma. Oral Dis 2011, 17(3):283-290. 10.1111/j.1601-0825.2010.01738.x, 21029261.
63. Yang YY, Woo ES, Reese CE, Bahnson RR, Saijo N, Lazo JS. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells. Mol Pharmacol 1994, 45(3):453-460.
64. Timmermann S, Hinds PW, Munger K. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senesence-like state. Oncogene 1998, 17(26):3445-3453.
65. Chang X, Monitto CL, Demokan S, Kim MS, Chang SS, Zhong X, Califano JA, Sidransky D. Identification of hypermethylated genes associated with cisplatin resistance in human cancers. Cancer Res 2010, 70(7):2870-2879. 10.1158/0008-5472.CAN-09-3427, 2849007, 20215521.